The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-methyl-N-(4-(4-nitrophenyl)thiazol-2-yl)-1,2,3-thiadiazole-5-carboxamide ID: ALA2252690
PubChem CID: 44128135
Max Phase: Preclinical
Molecular Formula: C13H9N5O3S2
Molecular Weight: 347.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nnsc1C(=O)Nc1nc(-c2ccc([N+](=O)[O-])cc2)cs1
Standard InChI: InChI=1S/C13H9N5O3S2/c1-7-11(23-17-16-7)12(19)15-13-14-10(6-22-13)8-2-4-9(5-3-8)18(20)21/h2-6H,1H3,(H,14,15,19)
Standard InChI Key: HOUPEVBOBPRINZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
11.2591 -14.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9668 -13.6983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5514 -13.6983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2591 -14.9241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4612 -12.8839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6619 -12.7140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2533 -13.4218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8001 -14.0290 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.6745 -14.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7644 -14.9193 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.5638 -15.0892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9724 -14.3814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4255 -13.7743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0670 -12.3355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7809 -14.2949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2608 -14.9576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0728 -14.8726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4059 -14.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9209 -13.4624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1106 -13.5508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2223 -14.0359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5536 -13.2889 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7035 -14.6963 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
3 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 3 1 0
2 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
5 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 15 1 0
21 22 2 0
21 23 1 0
18 21 1 0
M CHG 2 21 1 23 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.38Molecular Weight (Monoisotopic): 347.0147AlogP: 3.13#Rotatable Bonds: 4Polar Surface Area: 110.91Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.53CX Basic pKa: ┄CX LogP: 3.23CX LogD: 3.23Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.57Np Likeness Score: -2.85
References 1. Fan Z, Shi Z, Zhang H, Liu X, Bao L, Ma L, Zuo X, Zheng Q, Mi N.. (2009) Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance., 57 (10): [PMID:21314199 ] [10.1021/jf8031364 ]